Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06844097

Intervention for Medical Student to Promote Cervical Cancer Screening Among Latinx Transmasculine Individuals

The team aims to test the effectiveness of an intervention to increase gender-affirming cervical cancer prevention behaviors targeted at medical students studying in Puerto Rico and Florida. The team expects that after exposure to the intervention, relative to the control group, participants in the experimental condition will manifest more favorable changes in knowledge, attitudes, and behaviors of adequate care towards Latinx transmasculine and non-binary people.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

21 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

About this study

Transmen (TM) and non-binary individuals (NB; individuals assigned female sex at birth who identify as a man, male, or another diverse non-binary gender identity on the masculine spectrum) are at higher risk of screening-detectable cancers. Latinx TM-NB (LTM-NB) are at a higher risk for cervical cancer (CC) as they intersect two health disparity populations with high risk for this type of cancer (gender identity and ethnic minorities). Despite CC being highly preventable, LTM-NB individuals have been found to have lower rates of CC screening than cisgender female patients (persons who are not transgender). Unfortunately, findings from the team's previous funded studies with LTM-NB individuals in Puerto Rico (PR) and Florida evidence that providers lack knowledge regarding LTM-NB individual's healthcare needs, have negative stigmatizing attitudes, and manifest discriminatory behaviors in clinical interactions with LTM-NB individuals; which greatly limits their ability for engaging in recommended education and prevention guidelines of care for CC screening and prevention. In light of this, the research team (community stakeholders from PR and Mainland US, researchers, and providers) has developed a brief online intervention to improve medical students' competencies for cervical cancer education and screening promotion among LTM-NB individuals.

The proposed study aims to: 1) Test the effectiveness of the intervention in increasing medical students' knowledge, attitudes, and skills for providing healthcare to LTM-NB. , 2) Determine the acceptability, appropriateness, and feasibility of implementing the interventions in real-world medical educational settings.

While the team has preliminary data regarding the efficacy of the intervention, this pilot is proposing a rigorous study design: Aim 1 will measure the magnitude of effect of the intervention, and Aim 2 measures the implementation. This study will address cervical cancer disparities among LTM-NB individuals. The impact of this study will reveal new effective interventions and implementation strategies. The translational implications of this work will result in providing medical schools with a cross-cultural tool to train students on cervical cancer prevention for LTM-NB individuals.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Medical student currently in third year of medical school training

Exclusion criteria

  • Do not speak English

Treatment and study plan

Cervical Cancer Trans Inclusive Education (CC-TRAINED) Module

Behavioral

An online course designed to increase cervical cancer prevention clinical skills among medical students when working with Latinx transmasculine populations.

Disaster Preparedness Course

Behavioral

An online course designed to improve professionals' skills and competencies for engaging in disaster preparedness.

Primary outcomes

  1. Change cervical cancer preventive behaviors, as determined by the Cervical Cancer Preventive Behaviors Inventory

    Time frame: Baseline, immediately after the intervention

    The CCPBI includes 46 non-verbal and verbal behaviors that can be manifested during the SPS interactions with LTM. The team expects that following intervention exposure, relative to control group participants, intervention participants will manifest a higher mean number of CC preventive behaviors on the CCPBI outcome.

  2. Change in LTMNB knowledge, as determined by Transmasculine knowledge index

    Time frame: Baseline, immediately after the intervention

    This measure assesses health professionals' knowledge of TM-specific health issues. Intervention participants, relative to controls, will have a higher mean knowledge (literacy) level regarding LTM issues.

  3. Change negative attitudes towards LTMNB, as determined by the transgender stigma scale

    Time frame: Baseline, immediately after the intervention

    This scale measures stigma related to transgender identity among healthcare providers. Intervention participants, relative to controls, will have a lower mean level of stigmatizing attitudes toward LTM

  4. Change negative and increase positive emotions related to LTMNB, as determined by the Emotional Reactions Scale

    Time frame: Baseline, immediately after the intervention

    This scale measures emotional reactions to LTMNB. Intervention participants, relative to control participants, will have an increase in the mean of positive emotions, and a reduction in the mean level of negative emotions.

  5. Change cultural humility, as determined by the cross-cultural scale

    Time frame: Baseline, immediately after the intervention

    This adaptation of the Cross-Cultural Care Scale55 measures cultural humility preparedness and skills towards multiple identities. Intervention participants, relative to control participants, will have an increase in the mean of cultural humility.

Secondary outcomes

  1. Sex as a biological variable

    Time frame: Baseline, immediately after the intervention

    Following NIH guidance regarding investigating differential effects of sex and gender, we will repeat all analyses twice, stratified by a) sex at birth and b) current gender identification, respectively.

Study contacts

Contact information is provided by the study sponsor or research team.

Alixida Ramos-Pibernus, PhD

CONTACT

[email protected]

787-840-2575

Matthew B Schabath, PhD

CONTACT

[email protected]

813-745-4150

Sponsors and collaborators

Lead sponsor

Ponce Medical School Foundation, Inc.

Industry

Collaborators

  • H. Lee Moffitt Cancer Center and Research Institute
  • National Cancer Institute (NCI)

Registry information

Official study title

Testing the Effectiveness of an Intervention to Foster Cervical Cancer Screening Promotion for Latinx Trans Men Among Medical Students

Acronym: CC-Trained

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Feb 25, 2025
Registry last updated
Mar 4, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.